IRadimed Corp reports results for the quarter ended in March - Earnings Summary

IRADIMED

29/04/2022 14:31

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
22 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for earnings of
21 cents per share.
    * Revenue rose 33.5% to $12.31 million from a year ago; 
analysts
expected $12.21 million. 
    * IRadimed Corp's reported EPS for the quarter was 20
cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * IRadimed Corp shares had fallen by 8.2% this quarter and
lost 9.1% so far this year.
    * The company reported quarterly net income of $2.49
million.
    * Wall Street's median 12-month price target for IRadimed
Corp is
$51.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated April 29 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated